Teva Snaps Up Compliance Tracking Startup Gecko
By HospiMedica International staff writers Posted on 04 Oct 2015 |
Teva Pharmaceutical Industries (Teva; Petah Tikva, Israel) has acquired respiratory disease compliance startup Gecko Health Innovations (Gecko; Cambridge, MA, USA) for an undisclosed sum.
The purchase positions Teva with in-house medication compliance tracking capabilities for consumer use, leveraging a technology largely reserved for clinical trials into one available for everyday use by its customers. Gecko, founded in 2012, has focused so far on chronic obstructive pulmonary disease (COPD) and asthma compliance via its flagship product, CareTRx, which is comprised of a hardware device which attaches to most metered-dose inhalers (MDIs), as well as a software program which synchronizes and stores data through an app-based user interface to the cloud.
Together with Gecko Health Innovations, Teva will further explore new ways to apply the CareTRx technology to its robust pipeline and portfolio of respiratory products, with the goal of enhancing clinical outcomes for patients. The purchase also takes out of play one of a handful of high-profile startups in the medical compliance market, which include Propeller Health (Madison, WI, USA), whose sensor and digital health platform were approved for use with the in GlaxoSmithKline (GSK; London, United Kingdom) Diskus dry powder inhaler for asthma and COPD.
“The acquisition of Gecko Health Innovations further enhances Teva's ability to develop and deliver truly patient-centered solutions by utilizing eConnected, data-driven technology to improve the management of respiratory diseases,” said Rob Koremans, MD, President and CEO of Teva Global Specialty Medicines.
“During the last three years, we have designed and built a system to support respiratory disease management by intuitively connecting caregivers, patients, and families,” said Yechiel Engelhard, MD, CEO and Founder of Gecko Health Innovations. “Our vision was to connect chronic medication management into one platform, leveraging this information to support and empower patients by partnering with leading players in the healthcare and pharmaceutical industries. We are very excited to realize this vision as it aligns to Teva's focus on innovative patient solutions.”
Related Links:
Teva Pharmaceutical Industries
Gecko Health Innovations
Propeller Health
The purchase positions Teva with in-house medication compliance tracking capabilities for consumer use, leveraging a technology largely reserved for clinical trials into one available for everyday use by its customers. Gecko, founded in 2012, has focused so far on chronic obstructive pulmonary disease (COPD) and asthma compliance via its flagship product, CareTRx, which is comprised of a hardware device which attaches to most metered-dose inhalers (MDIs), as well as a software program which synchronizes and stores data through an app-based user interface to the cloud.
Together with Gecko Health Innovations, Teva will further explore new ways to apply the CareTRx technology to its robust pipeline and portfolio of respiratory products, with the goal of enhancing clinical outcomes for patients. The purchase also takes out of play one of a handful of high-profile startups in the medical compliance market, which include Propeller Health (Madison, WI, USA), whose sensor and digital health platform were approved for use with the in GlaxoSmithKline (GSK; London, United Kingdom) Diskus dry powder inhaler for asthma and COPD.
“The acquisition of Gecko Health Innovations further enhances Teva's ability to develop and deliver truly patient-centered solutions by utilizing eConnected, data-driven technology to improve the management of respiratory diseases,” said Rob Koremans, MD, President and CEO of Teva Global Specialty Medicines.
“During the last three years, we have designed and built a system to support respiratory disease management by intuitively connecting caregivers, patients, and families,” said Yechiel Engelhard, MD, CEO and Founder of Gecko Health Innovations. “Our vision was to connect chronic medication management into one platform, leveraging this information to support and empower patients by partnering with leading players in the healthcare and pharmaceutical industries. We are very excited to realize this vision as it aligns to Teva's focus on innovative patient solutions.”
Related Links:
Teva Pharmaceutical Industries
Gecko Health Innovations
Propeller Health
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures